Trademark: ASTREA PHARMA
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for ASTREA PHARMA
We do not have any records of a proof of use for ASTREA PHARMA at this moment.
Possible trademark infringements of ASTREA PHARMA
Basic Information about ASTREA PHARMA
- Serial Number
- 97227927
- Filing Date
- 19 Jan 2022
- Mark Drawing Code
- 5
Classifications
Declare the trademark use of ASTREA PHARMA on the blockchain with WikiTrademarks.io.
- First use of ASTREA PHARMA anywhere
- ASTREA PHARMA was first used on 31 Jan 2020 for the primary classification of goods and services, international, 040 (Treatment of materials)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 040
- US Codes
- 100; 103; 106
- First use of ASTREA PHARMA anywhere
- ASTREA PHARMA was first used on 31 Jan 2020 for the primary classification of goods and services, international, 042 (Computer, scientific & legal)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 042
- US Codes
- 100; 101
Who owns ASTREA PHARMA?
1. Astrea SA Luxembourg
Correspondent
- Jeffrey B. Sladkus, Esq.
- THE SLADKUS LAW GROUP
- 1397 CARROLL DRIVE
- ATLANTA GA 30318
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io